Ernexa Therapeutics Inc. Increase (Decrease) in Other Operating Liabilities
Ernexa Therapeutics Inc. (ERNA) reported Increase (Decrease) in Other Operating Liabilities of -$1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$94.00K.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $93.00K.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$49.00K.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$63.00K.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $15.00K, a 44.44% decline from fiscal 2024.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for fiscal 2024 was $27.00K.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$374.00K, a 341.29% decline from fiscal 2022.
- Ernexa Therapeutics Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $155.00K, a 520.00% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.00K 10-Q · filed 2026-08-06 | -$50.00K derived: sum of 3 quarters · filed 2026-08-06 | -$113.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $93.00K 10-Q · filed 2026-05-11 | $44.00K derived: sum of 2 quarters · filed 2026-05-11 | -$19.00K derived: sum of 3 quarters · filed 2026-05-11 | |||||
| 2025-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$112.00K derived: sum of 2 quarters · filed 2026-03-13 | $15.00K 10-K · filed 2026-03-13 | |||||
| 2025-09-30 | -$63.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $64.00K 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | $127.00K 10-Q · filed 2026-08-06 | |||||||
| 2024-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$198.00K derived: sum of 2 quarters · filed 2026-03-13 | $27.00K derived: sum of 3 quarters · filed 2026-03-13 | $27.00K 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | -$112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $113.00K derived: sum of 2 quarters · filed 2025-11-07 | $113.00K 10-Q · filed 2025-11-07 | $108.00K derived: sum of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | $225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $225.00K 10-Q · filed 2025-08-13 | $220.00K derived: sum of 3 quarters · filed 2025-08-13 | -$229.00K derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-14 | -$5.00K derived: sum of 2 quarters · filed 2025-03-12 | -$454.00K derived: sum of 3 quarters · filed 2025-03-12 | -$12.00K derived: sum of 4 quarters · filed 2025-03-12 | ||||
| 2023-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | -$454.00K derived: sum of 2 quarters · filed 2025-03-12 | -$12.00K derived: sum of 3 quarters · filed 2025-03-12 | -$374.00K 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$7.00K derived: sum of 2 quarters · filed 2024-11-12 | -$369.00K 10-Q · filed 2024-11-12 | -$864.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $80.00K 10-Q · filed 2024-08-13 | -$415.00K derived: sum of 3 quarters · filed 2024-08-13 | -$948.00K derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$362.00K 10-Q · filed 2024-05-14 | -$857.00K derived: sum of 2 quarters · filed 2024-05-14 | -$1.39M derived: sum of 3 quarters · filed 2024-05-14 | -$5.00K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | -$495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$1.03M derived: sum of 2 quarters · filed 2024-03-14 | $357.00K derived: sum of 3 quarters · filed 2024-03-14 | $155.00K 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | -$533.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $852.00K derived: sum of 2 quarters · filed 2023-11-13 | $650.00K 10-Q · filed 2023-11-13 | $4.04M 10-Q · filed 2022-11-14 | $473.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.18M 10-Q · filed 2023-08-11 | $1.01M derived: sum of 3 quarters · filed 2023-08-11 | $226.00K derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$202.00K 10-Q · filed 2023-05-11 | -$379.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.16M derived: sum of 3 quarters · filed 2023-05-11 | -$177.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$957.00K derived: sum of 2 quarters · filed 2023-03-20 | $25.00K derived: sum of 3 quarters · filed 2023-03-20 | $25.00K 10-K · filed 2023-03-20 | $0.00 10-K · filed 2022-04-15 | |||
| 2021-09-30 | -$780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $202.00K derived: sum of 2 quarters · filed 2022-11-14 | $202.00K 10-Q · filed 2022-11-14 | $0.00 10-Q · filed 2021-11-12 | $209.16K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $982.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $982.00K 10-Q · filed 2022-08-11 | $0.00 10-Q · filed 2021-08-13 | $989.16K derived: sum of 3 quarters · filed 2022-08-11 | $996.68K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-07-01 | $7.16K derived: sum of 2 quarters · filed 2022-07-01 | $14.68K derived: sum of 3 quarters · filed 2022-07-01 | $24.32K derived: sum of 4 quarters · filed 2022-07-01 | ||||
| 2020-12-31 | $7.16K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | $14.68K derived: sum of 2 quarters · filed 2022-07-01 | $24.32K derived: sum of 3 quarters · filed 2022-07-01 | $25.00K 10-K/A · filed 2022-07-01 | -$305.00K 10-K · filed 2021-03-11 | |||
| 2020-09-30 | $7.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $17.16K derived: sum of 2 quarters · filed 2021-11-12 | $17.84K 10-Q · filed 2021-11-12 | -$291.00K 10-Q · filed 2020-11-13 | $266.84K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $9.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $10.32K 10-Q · filed 2021-08-13 | -$201.00K 10-Q · filed 2020-08-07 | $259.32K derived: sum of 3 quarters · filed 2021-08-13 | $95.32K derived: sum of 4 quarters · filed 2021-08-13 | |||
| 2020-03-31 | $685.00 10-Q · filed 2021-05-17 | -$144.00K 10-Q · filed 2020-05-20 | $249.69K derived: sum of 2 quarters · filed 2021-05-17 | $85.69K derived: sum of 3 quarters · filed 2021-05-17 | $142.69K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $85.00K derived: sum of 2 quarters · filed 2021-03-11 | $142.00K derived: sum of 3 quarters · filed 2021-03-11 | $108.00K 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | -$164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$107.00K derived: sum of 2 quarters · filed 2020-11-13 | -$141.00K 10-Q · filed 2020-11-13 | -$103.00K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $23.00K 10-Q · filed 2020-08-07 | $61.00K derived: sum of 3 quarters · filed 2020-08-07 | $44.00K derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | -$34.00K 10-Q · filed 2020-05-20 | $4.00K derived: sum of 2 quarters · filed 2020-05-20 | -$13.00K derived: sum of 3 quarters · filed 2020-05-20 | $54.00K derived: sum of 4 quarters · filed 2020-05-20 | ||||
| 2018-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $21.00K derived: sum of 2 quarters · filed 2020-03-19 | $88.00K derived: sum of 3 quarters · filed 2020-03-19 | $41.00K 10-K · filed 2020-03-19 | ||||
| 2018-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $50.00K derived: sum of 2 quarters · filed 2019-11-01 | $3.00K 10-Q · filed 2019-11-01 | -$97.00K 10-Q · filed 2018-11-09 | $89.00K derived: sum of 4 quarters · filed 2019-11-01 | |||
| 2018-06-30 | $67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $20.00K 10-Q · filed 2019-08-12 | -$94.00K 10-Q · filed 2018-08-06 | $106.00K derived: sum of 3 quarters · filed 2019-08-12 | $47.00K derived: sum of 4 quarters · filed 2019-08-12 | |||
| 2018-03-31 | -$47.00K 10-Q · filed 2019-05-14 | $39.00K derived: sum of 2 quarters · filed 2019-05-14 | -$20.00K derived: sum of 3 quarters · filed 2019-05-14 | -$201.00K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $27.00K derived: sum of 2 quarters · filed 2019-03-22 | -$154.00K derived: sum of 3 quarters · filed 2019-03-22 | -$99.00K 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | -$59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$240.00K derived: sum of 2 quarters · filed 2018-11-09 | -$185.00K 10-Q · filed 2018-11-09 | -$109.00K derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | -$181.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$126.00K 10-Q · filed 2018-08-06 | -$50.00K derived: sum of 3 quarters · filed 2018-08-06 | -$120.00K derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | $55.00K 10-Q · filed 2018-05-11 | $131.00K derived: sum of 2 quarters · filed 2018-05-11 | $61.00K derived: sum of 3 quarters · filed 2018-05-11 | -$189.00K derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $6.00K derived: sum of 2 quarters · filed 2018-03-09 | -$244.00K derived: sum of 3 quarters · filed 2018-03-09 | -$348.00K 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$320.00K derived: sum of 2 quarters · filed 2017-11-08 | -$424.00K 10-Q · filed 2017-11-08 | -$97.00K derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$354.00K 10-Q · filed 2017-08-04 | -$27.00K derived: sum of 3 quarters · filed 2017-08-04 | $139.00K derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | -$104.00K 10-Q · filed 2017-05-04 | $223.00K derived: sum of 2 quarters · filed 2017-05-04 | $389.00K derived: sum of 3 quarters · filed 2017-05-04 | $147.00K derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $493.00K derived: sum of 2 quarters · filed 2017-03-09 | $251.00K derived: sum of 3 quarters · filed 2017-03-09 | $159.00K 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$76.00K derived: sum of 2 quarters · filed 2016-11-09 | -$168.00K 10-Q · filed 2016-11-09 | |||||
| 2015-06-30 | -$242.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$334.00K 10-Q · filed 2016-08-04 | ||||||
| 2015-03-31 | -$92.00K 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |